For example, berberine and curcumin have been investigated to inhibit Aβ and α-synuclein accumulation in AD model APP/tau/PS1 transgenic mice and lipopolysaccharide-induced PD mouse model, respectively [14,15]. This evidence concerns the gene APP and Alzheimer disease.